TRCT
CYNA

Tower Research Capital (TRC)’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Tower Research Capital (TRC)’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-800
Closed -$42K – 4936
2016
Q3 		$42K Sell
800
-64
-7% -$1.58K ﹤0.01% 1239
2016
Q2 		$14K Buy
+864
New +$11.6K ﹤0.01% 2565
2016
Q1 		– Sell
-140
Closed -$2K – 5574
2015
Q4 		$2K Sell
140
-373
-73% -$5.67K ﹤0.01% 3935
2015
Q3 		$8K Sell
513
-87
-15% -$1.41K ﹤0.01% 2527
2015
Q2 		$10K Buy
+600
New +$9.84K ﹤0.01% 2754

Tower Research Capital (TRC)'s CYNA Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 800 shares — an estimated $42K sold.

Tower Research Capital (TRC) first reported a position in CYNA in Q2 2015 and held it in 5 quarters. The position peaked at $42K in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • Tower Research Capital (TRC) reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 800 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $42K.
  • Tower Research Capital (TRC) first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $42K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.